Shares in Marmite maker Unilever are sharply lower after it made an audacious swoop for GlaxoSmithKline's consumer healthcare arm.
The food giant told investors that the Glaxo unit is a “strong strategic fit” as part of it pursuit of sales categories with higher rates of sustainable growth.
The developments came as the City also digested the resignation of former Lloyds boss António Horta-Osório as chairman of Credit Suisse.
